Catalyst Wire Dossier Catalyst Wire Dossier

Irbesartan/Hydrochlorothiazide Teva

irbesartan/hydrochlorothiazide · Teva B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Irbesartan/Hydrochlorothiazide Teva, covering 2026-01-16 to 2026-01-16. Get the full timeline:

Most recent: EMA Authorised: Irbesartan/Hydrochlorothiazide Teva (irbesartan;hydrochlorothiazide) — Teva B.V.

See pricing